AMLX Stock-Based Compensation
Amylyx Pharmaceuticals Inc · Stock-Based Compensation
AMLX Stock-Based Compensation
Latest reported$27.90Mperiod ending
AMLX TTM Stock-Based Comp ($1.24M → $27.90M)
TTM stock-based compensation
High-resolution chart · PNG
AMLX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 27,900,000 | |
| 26,932,000 | |
| 27,645,000 | |
| 28,000,000 | |
| 27,727,000 | |
| 29,947,000 | |
| 33,038,000 | |
| 35,831,000 | |
| 39,204,000 | |
| 39,584,000 | |
| 37,161,000 | |
| 33,718,000 | |
| 29,066,000 | |
| 24,823,000 | |
| 21,714,000 | |
| 16,714,000 | |
| 11,190,000 | |
| 6,140,000 | |
| 2,334,000 | |
| 1,243,000 |